1
Clinical Trials associated with Umbilical Cord-derived Mesenchymal Stem Cells(The General Hospital of Shenyang Military Region)Umbilical Cord-derived Mesenchymal Stem Cells for Ischemic Stroke (UMSIS): a Prospective, Double-blinded, Randomized Controlled, Pilot Study
This is a doble blind, placebo controlled clinical trial to assess safety and efficacy of intravenous administration of Umbilical cord-derived Mesenchymal Stem cells in patients with ischemic stroke within 6 months of onset.
100 Clinical Results associated with Umbilical Cord-derived Mesenchymal Stem Cells(The General Hospital of Shenyang Military Region)
100 Translational Medicine associated with Umbilical Cord-derived Mesenchymal Stem Cells(The General Hospital of Shenyang Military Region)
100 Patents (Medical) associated with Umbilical Cord-derived Mesenchymal Stem Cells(The General Hospital of Shenyang Military Region)
100 Deals associated with Umbilical Cord-derived Mesenchymal Stem Cells(The General Hospital of Shenyang Military Region)